Showing results (3081-3090 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|August 22, 2013
The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigueAlan Carlotto, Virginia L Hogsett, Elyse M Maiorini, et al.Pharmacoeconomics|July 2, 2013
Does economic incentive matter for rational use of medicine? China's experience from the essential medicines programMingsheng Chen, Lijie Wang, Wen Chen, et al.Pharmacoeconomics|July 11, 2013
Protease inhibitors for hepatitis C: economic implicationsStuart J Turner, Jack Brown, Joseph A PaladinoPharmacoeconomics|March 14, 2012
Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issuesMaureen P M H Rutten-van Mölken, Lucas M A GoossensPharmacoeconomics|February 20, 2016
Trastuzumab Emtansine for Treating HER2-Positive, Unresectable, Locally Advanced or Metastatic Breast Cancer After Treatment with Trastuzumab and a Taxane: An Evidence Review Group Perspective of a NICE Single Technology AppraisalHazel Squires, Matt Stevenson, Emma Simpson, et al.Pharmacoeconomics|February 23, 2016
Cost Implications of Value-Based Pricing for Companion Diagnostic Tests in Precision MedicineGregory S ZaricPharmacoeconomics|December 15, 2015
AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model UsersP Vemer, I Corro Ramos, G A K van Voorn, et al.Pharmacoeconomics|November 26, 2013
Assessing the cost effectiveness of pre-exposure prophylaxis for HIV prevention in the USFred J HellingerPharmacoeconomics|November 26, 2013
Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequencesJeffrey F Barletta, David A SclarPageof 336